The high disapproval of Dilma Roussef’s administration and the country’s erroneous direction result in nearly 60% of support for the impeachment - which is lower (43%) in classes D and E.
Consumer’s confidence has reached the lowest level considering all the historical series, and is at 64 points.
A country in economic depression, political instability and injured pride. What are the main problems to be solved to revert this situation?
This report reveals the latest developments in eating and drinking in China, from attitudes on organic produce, to innovation and personalising the packaging and even the product itself.
In China's first- and second-tier cities. With the awakening of fine living and fashion consciousness, Chinese female consumers' demand for skin care and beauty develops constantly. What kind of skin care and beauty demand do they have? What are the features of their product function demand?
The national economic assessment average is showing signs of recovery. With positive gains for a second month in a row, 38% of global citizens view their current economic situation as “good”, up one point since last sounding.
Presented at the Tutto Food conference, the largest Food Trade Fair in Italy, this report into current and future Italian food trends suggests fresh food will remain popular and predicts that online spending will increase.
In recent years, attitudes toward the richest 1% of Americans have increasingly become part of the national conversation. Some vilify “The 1%,” others want to join their ranks, and many hold both attitudes at once – viewing the wealthy with a sometimes paradoxical mix of anger, envy and aspiration.
On April 6th, Dutch voters were given the chance to decide whether the EU should close a trade agreement with Ukraine. Ipsos accurate polling dominates media in the Dutch Referendum.
Non-alcoholic Steatohepatitis, or NASH, is a liver disease characterized by rising prevalence, low diagnosis and a lack of therapies approved for treatment. All of these factors combine to make NASH a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. Accordingly, the race is now on among several pharma companies to develop the first effective pharmacotherapy to treat NASH.
